Terms: = Germ cell tumor AND FGFR1OP, FOP, 11116, ENSG00000213066
27 results:
1. Circ
Li J; Ma J; Huang S; Li J; Zhou L; Sun J; Chen L
Mol Cell Biol; 2023; 43(7):354-369. PubMed ID: 37427890
[TBL] [Abstract] [Full Text] [Related]
2. ADAMTS9-AS1 Long Non‑coding RNA Sponges miR‑128 and miR-150 to Regulate Ras/MAPK Signaling Pathway in Glioma.
Javanmard AR; Jahanbakhshi A; Nemati H; Mowla SJ; Soltani BM
Cell Mol Neurobiol; 2023 Jul; 43(5):2309-2322. PubMed ID: 36449154
[TBL] [Abstract] [Full Text] [Related]
3. circTOP2A functions as a ceRNA to promote glioma progression by upregulating RPN2.
Sun J; Wang J; Li M; Li S; Li H; Lu Y; Li F; Xin T; Jin F
Cancer Sci; 2023 Feb; 114(2):490-503. PubMed ID: 36227125
[TBL] [Abstract] [Full Text] [Related]
4. miR-363-3p induces EMT via the Wnt/β-catenin pathway in glioma cells by targeting CELF2.
Fan B; Su B; Song G; Liu X; Yan Z; Wang S; Hu F; Yang J
J Cell Mol Med; 2021 Nov; 25(22):10418-10429. PubMed ID: 34636136
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression.
Sun J; Ma Q; Shu C; Xiong J; Li B; Wu J; Zhang S; Li J; Liu J; Wang J
Int J Oncol; 2021 Jan; 58(1):45-56. PubMed ID: 33367931
[TBL] [Abstract] [Full Text] [Related]
6. Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors.
Engers DW; Bollinger SR; Felts AS; Vadukoot AK; Williams CH; Blobaum AL; Lindsley CW; Hong CC; Hopkins CR
Bioorg Med Chem Lett; 2020 Sep; 30(18):127418. PubMed ID: 32750526
[TBL] [Abstract] [Full Text] [Related]
7. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract] [Full Text] [Related]
8. MiR-449b-5p inhibits human glioblastoma cell proliferation by inactivating WNT2B/Wnt/β-catenin signaling pathway.
Hou WZ; Chen XL; Qin LS; Xu ZJ; Liao GM; Chen D; Hu LJ; Mao ZM; -S Huang J; Yuan Q; Liao C; Yao QM
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5549-5557. PubMed ID: 32495889
[TBL] [Abstract] [Full Text] [Related]
9. ALK2: A Therapeutic Target for Fibrodysplasia Ossificans Progressiva and Diffuse Intrinsic Pontine Glioma.
Sekimata K; Sato T; Sakai N
Chem Pharm Bull (Tokyo); 2020; 68(3):194-200. PubMed ID: 32115526
[TBL] [Abstract] [Full Text] [Related]
10. Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients.
Ognibene M; Morini M; Garaventa A; Podestà M; Pezzolo A
Cancer Biol Ther; 2020 May; 21(5):391-399. PubMed ID: 31959052
[TBL] [Abstract] [Full Text] [Related]
11. ACVR1 Function in Health and Disease.
Valer JA; Sánchez-de-Diego C; Pimenta-Lopes C; Rosa JL; Ventura F
Cells; 2019 Oct; 8(11):. PubMed ID: 31683698
[No Abstract] [Full Text] [Related]
12. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract] [Full Text] [Related]
13. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract] [Full Text] [Related]
14. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ
J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578
[TBL] [Abstract] [Full Text] [Related]
15. Fear of cancer progression in patients with stage IA malignant melanoma.
Wagner T; Augustin M; Blome C; Forschner A; Garbe C; Gutzmer R; Hauschild A; Heinzerling L; Livingstone E; Loquai C; Schadendorf D; Terheyden P; Mueller-Brenne T; Kähler KC
Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12901. PubMed ID: 30126009
[TBL] [Abstract] [Full Text] [Related]
16. RUNX3 inhibits glioma survival and invasion via suppression of the β-catenin/TCF-4 signaling pathway.
Sun J; Li B; Jia Z; Zhang A; Wang G; Chen Z; Shang Z; Zhang C; Cui J; Yang W
J Neurooncol; 2018 Oct; 140(1):15-26. PubMed ID: 29916101
[TBL] [Abstract] [Full Text] [Related]
17. Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders.
Machiya A; Tsukamoto S; Ohte S; Kuratani M; Fujimoto M; Kumagai K; Osawa K; Suda N; Bullock AN; Katagiri T
Bone; 2018 Jun; 111():101-108. PubMed ID: 29551750
[TBL] [Abstract] [Full Text] [Related]
18. Mechanism of MicroRNA-708 Targeting BAMBI in cell Proliferation, Migration, and Apoptosis in Mice With Melanoma via the Wnt and TGF-β Signaling Pathways.
Lu HJ; Yan J; Jin PY; Zheng GH; Zhang HL; Bai M; Wu DM; Lu J; Zheng YL
Technol Cancer Res Treat; 2018 Jan; 17():1533034618756784. PubMed ID: 29466930
[TBL] [Abstract] [Full Text] [Related]
19. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1.
Feng ZY; Xu XH; Cen DZ; Luo CY; Wu SB
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4844-4852. PubMed ID: 29164578
[TBL] [Abstract] [Full Text] [Related]
20. Shared ACVR1 mutations in fop and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases.
Han HJ; Jain P; Resnick AC
Bone; 2018 Apr; 109():91-100. PubMed ID: 28780023
[TBL] [Abstract] [Full Text] [Related]
[Next]
